Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 81: Use of phentolamine is of relatively little value in which of the following situations?

A. Treatment of essential hypertension. (Correct Answer)
B. Prevention of hypertension during operative removal of pheochromocytoma.
C. Treatment of male sexual dysfunction.
D. Treatment of hypertension due to clonidine withdrawal.

Explanation: **Explanation:** **Phentolamine** is a competitive, non-selective alpha-adrenergic blocker ($\alpha_1$ and $\alpha_2$). Understanding its mechanism is key to identifying its clinical utility. **1. Why Option A is the correct answer:** Phentolamine is of little value in **essential hypertension** because it causes **reflex tachycardia** and a significant increase in cardiac output. This occurs because blocking presynaptic $\alpha_2$ receptors removes the "negative feedback" on norepinephrine release. The resulting excess norepinephrine stimulates $\beta_1$ receptors in the heart, leading to palpitations and potential arrhythmias. Additionally, its short duration of action and the risk of severe orthostatic hypotension make it impractical for chronic management compared to selective $\alpha_1$ blockers (like Prazosin) or other antihypertensives. **2. Analysis of Incorrect Options:** * **B. Pheochromocytoma:** Phentolamine is highly effective here to manage catecholamine surges during surgery. It provides rapid, reversible blockade of $\alpha$-receptors to prevent hypertensive crises during tumor manipulation. * **C. Male Sexual Dysfunction:** Phentolamine (often injected intracavernosally with papaverine) causes vasodilation of the penile arteries, facilitating erection. * **D. Clonidine Withdrawal:** Sudden cessation of clonidine leads to a massive sympathetic "rebound" with high circulating catecholamines. Phentolamine is the drug of choice to rapidly counteract this $\alpha$-mediated vasoconstriction. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** For hypertensive crises due to **Cheese Reaction** (MAOIs + Tyramine) and **Cocaine toxicity** is Phentolamine. * **Diagnosis:** Historically, the "Phentolamine Test" was used for pheochromocytoma (a drop in BP >35/25 mmHg), though it is now replaced by biochemical assays. * **Extravasation:** It is used locally to prevent tissue necrosis following the extravasation of alpha-agonists like Norepinephrine.

Question 82: Sibutramine is indicated for:

A. Smoking cessation
B. Obesity (Correct Answer)
C. Weight loss
D. Mania

Explanation: **Explanation:** **Sibutramine** is a centrally acting drug primarily used in the management of **Obesity**. **Mechanism of Action:** It acts as a **Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)**. By inhibiting the reuptake of these neurotransmitters in the hypothalamus, it enhances satiety (feeling of fullness) and increases basal metabolic rate (thermogenesis), leading to significant weight reduction. **Analysis of Options:** * **B. Obesity (Correct):** It is indicated as an adjunct to diet and exercise for patients with a high Body Mass Index (BMI). While it causes "weight loss," the clinical indication is specifically the medical condition of **Obesity**. * **A. Smoking cessation:** Drugs like **Varenicline** (partial nicotinic agonist) and **Bupropion** (NDRI) are used for this purpose, not Sibutramine. * **C. Weight loss:** While Sibutramine causes weight loss, "Obesity" is the formal medical diagnosis/indication. In competitive exams like NEET-PG, the clinical condition (Obesity) is preferred over the symptom/outcome (Weight loss). * **D. Mania:** Sibutramine can actually precipitate mania or anxiety due to increased catecholamine levels; it is never used to treat it. Lithium or Valproate are standard treatments for mania. **High-Yield Clinical Pearls for NEET-PG:** * **Cardiovascular Risks:** Sibutramine was withdrawn from many markets (including India and the US) because it increases heart rate and blood pressure, leading to a higher risk of **myocardial infarction and stroke**. * **Contraindications:** It is strictly contraindicated in patients with a history of coronary artery disease, congestive heart failure, or arrhythmias. * **Other Anti-obesity Drugs:** Compare with **Orlistat** (inhibits gastric/pancreatic lipases) and **Lorcaserin** (5-HT2C agonist).

Question 83: Which of the following is a directly acting cholinergic drug?

A. Pilocarpine
B. Bethanechol
C. Methacholine
D. All of the above (Correct Answer)

Explanation: ### Explanation **Concept:** Cholinergic drugs (parasympathomimetics) are classified into two main categories based on their mechanism of action: **Directly acting** agonists and **Indirectly acting** agents (Anticholinesterases) [2]. Directly acting drugs bind to and activate muscarinic or nicotinic receptors directly, mimicking the effects of acetylcholine [2]. **Analysis of Options:** * **Pilocarpine:** A natural alkaloid that acts directly on muscarinic receptors [1]. It is primarily used in ophthalmology to treat glaucoma (miotic) and to treat xerostomia (Sjogren’s syndrome) [4]. * **Bethanechol:** A synthetic choline ester that is highly resistant to acetylcholinesterase [1]. It acts selectively on muscarinic receptors (M3) and is used clinically to treat post-operative urinary retention and paralytic ileus [3]. * **Methacholine:** A synthetic analog of acetylcholine. It is primarily used in the "Methacholine Challenge Test" to diagnose bronchial hyperreactivity in suspected asthma cases [4]. Since all three drugs interact directly with cholinergic receptors rather than inhibiting the enzyme acetylcholinesterase, **Option D (All of the above)** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Choline Esters:** **A**cetylcholine, **C**arbachol, **M**ethacholine, **B**ethanechol (**A**ll **C**holine **M**ust **B**ind). * **Bethanechol** is "purely muscarinic" and has negligible nicotinic activity, making it safe for bowel/bladder stimulation [3]. * **Pilocarpine** is the drug of choice for acute angle-closure glaucoma to rapidly induce miosis. * **Cevimeline** is another directly acting drug specifically used for Sjogren’s syndrome due to its M3 selectivity [5].

Question 84: Which neuromuscular blocker does not require reversal of its action by neostigmine at the end of the operation?

A. Pipecuronium
B. d-Tubocurarine
C. Mivacurium (Correct Answer)
D. Doxacurium

Explanation: **Explanation:** The correct answer is **Mivacurium (Option C)**. **Why Mivacurium is the correct answer:** Mivacurium is a short-acting, non-depolarizing neuromuscular blocker (NMB). Its unique pharmacokinetic profile is defined by its rapid metabolism by **plasma pseudocholinesterase** (butyrylcholinesterase), similar to succinylcholine. Because it is inactivated so quickly by enzymes naturally present in the blood, its effects wear off spontaneously within 15–20 minutes. Therefore, pharmacological reversal with an acetylcholinesterase inhibitor like **Neostigmine** is often unnecessary, as the natural recovery is rapid. **Analysis of Incorrect Options:** * **Pipecuronium (A) & Doxacurium (D):** These are **long-acting** benzylisoquinolinium/aminosteroid compounds. They have a slow onset and a very long duration of action (often >60–90 minutes). They require active reversal with neostigmine to ensure adequate respiratory function post-surgery. * **d-Tubocurarine (B):** This is the prototype **long-acting** non-depolarizing NMB. It is rarely used today due to its side effect profile (histamine release and ganglion blockade) and always requires reversal due to its prolonged duration. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest acting non-depolarizing NMB:** Mivacurium. * **Shortest acting NMB overall:** Succinylcholine (Depolarizing). * **Hoffman Elimination:** Remember that **Atracurium** and **Cisatracurium** undergo spontaneous degradation (Hoffman elimination) and are the drugs of choice in patients with liver or kidney failure. * **Neostigmine Mechanism:** It works by inhibiting acetylcholinesterase, increasing ACh levels at the NMJ to outcompete the non-depolarizing blocker. It is always co-administered with **Glycopyrrolate** or Atropine to prevent muscarinic side effects (bradycardia).

Question 85: Which drug class increases trabecular outflow in glaucoma?

A. Beta-blockers
B. Carbonic anhydrase inhibitors
C. Miotics (Correct Answer)
D. Prostaglandin analogues

Explanation: **Explanation:** The management of glaucoma focuses on reducing intraocular pressure (IOP) by either decreasing the production of aqueous humor or increasing its drainage. Drainage occurs via two pathways: the **trabecular meshwork** (conventional) and the **uveoscleral pathway** (unconventional). **Why Miotics are correct:** Miotics (e.g., **Pilocarpine**) are direct-acting cholinergic agonists. They cause contraction of the **ciliary muscle**, which pulls on the scleral spur. This mechanical action opens up the spaces in the **trabecular meshwork**, thereby directly increasing the trabecular outflow of aqueous humor. **Analysis of Incorrect Options:** * **Beta-blockers (e.g., Timolol):** These drugs work by blocking $\beta_2$ receptors on the ciliary epithelium, thereby **decreasing the production** of aqueous humor. They do not affect outflow. * **Carbonic Anhydrase Inhibitors (e.g., Acetazolamide, Dorzolamide):** These agents inhibit the enzyme carbonic anhydrase in the ciliary body, leading to a **reduction in the secretion** of aqueous humor. * **Prostaglandin Analogues (e.g., Latanoprost):** While these are first-line drugs for glaucoma, they primarily increase **uveoscleral outflow**, not trabecular outflow. **High-Yield NEET-PG Pearls:** * **Miotics** are the drug of choice for **Acute Angle Closure Glaucoma** (after initial pressure reduction) because they cause miosis, pulling the iris away from the angle. * **Prostaglandin analogues** are the first-line treatment for **Primary Open Angle Glaucoma (POAG)**. * **Apraclonidine** (Alpha-2 agonist) is frequently used to prevent IOP spikes after laser trabeculoplasty. * **Mnemonic for Outflow:** **M**iotics = **M**eshwork (Trabecular); **P**rostaglandins = **P**assage via Uveoscleral.

Question 86: Which of the following is the only non-catecholamine sympathomimetic drug?

A. Adrenaline
B. Ephedrine (Correct Answer)
C. Dopamine
D. Isoprenaline

Explanation: ### Explanation The classification of sympathomimetics into catecholamines and non-catecholamines is based on their chemical structure and pharmacological properties. **1. Why Ephedrine is the Correct Answer:** Sympathomimetics are categorized based on the presence of a **catechol nucleus** (a benzene ring with hydroxyl groups at the 3rd and 4th positions). **Ephedrine** lacks these hydroxyl groups, making it a **non-catecholamine**. * **Key Properties of Non-catecholamines:** They are resistant to degradation by the enzyme COMT (Catechol-O-methyltransferase), leading to a longer duration of action. They are also more lipid-soluble, allowing them to cross the blood-brain barrier (BBB) and exert CNS effects. **2. Analysis of Incorrect Options:** * **Adrenaline (Option A):** A naturally occurring endogenous catecholamine acting on $\alpha$ and $\beta$ receptors. * **Dopamine (Option C):** An endogenous catecholamine and a precursor to norepinephrine. * **Isoprenaline (Option D):** A synthetic catecholamine that acts as a potent, non-selective $\beta$-receptor agonist. * *Note:* All three (A, C, and D) contain the catechol nucleus, are metabolized by COMT, and have poor CNS penetration. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Ephedrine:** It is a **mixed-acting sympathomimetic**; it acts directly on receptors and indirectly by displacing norepinephrine from storage vesicles. * **Clinical Use:** Historically used for bronchial asthma and spinal anesthesia-induced hypotension. * **Tachyphylaxis:** Ephedrine is notorious for causing tachyphylaxis (rapidly diminishing response to repeated doses) due to the depletion of norepinephrine stores. * **Rule of Thumb:** If the drug name ends in "-ine" but lacks "hydroxy" groups at the 3,4 positions (e.g., Ephedrine, Amphetamine, Phenylephrine), it is generally a non-catecholamine.

Question 87: A drug is shown to activate dopaminergic D1 and D2 and adrenergic α and β1 but not β2 receptors. Which of the following can be the drug being talked about?

A. Dopamine (Correct Answer)
B. Dobutamine
C. Methoxamine
D. Phenylephrine

Explanation: ### Explanation **1. Why Dopamine is Correct:** Dopamine is a unique catecholamine that exhibits **dose-dependent receptor activation**. Its pharmacological profile perfectly matches the question: * **Low dose (0.5–2 µg/kg/min):** Primarily acts on **D1 and D2 receptors** in the renal and mesenteric vasculature, causing vasodilation. * **Medium dose (2–10 µg/kg/min):** Stimulates **β1 receptors** in the heart, increasing contractility and cardiac output. * **High dose (>10 µg/kg/min):** Activates **α1 receptors**, leading to systemic vasoconstriction. Crucially, Dopamine has **no significant action on β2 receptors**, which distinguishes it from Epinephrine. **2. Why Other Options are Incorrect:** * **Dobutamine:** It is a relatively selective **β1 agonist** with minor β2 and α1 activity. It lacks dopaminergic (D1/D2) activity. It is primarily used as an inotrope in cardiogenic shock. * **Methoxamine:** This is a selective **α1 agonist**. It has no action on β or dopamine receptors. It is rarely used clinically today but was historically used to treat paroxysmal supraventricular tachycardia (PSVT) via reflex bradycardia. * **Phenylephrine:** A selective **α1 agonist**. Like methoxamine, it lacks β and dopamine receptor activity. It is commonly used as a nasal decongestant and to maintain blood pressure during spinal anesthesia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Fenoldopam:** A selective **D1 agonist** used in hypertensive emergencies; it maintains renal perfusion while lowering BP. * **Dopamine in Shock:** While historically popular, it is now often second-line to Norepinephrine in septic shock due to a higher risk of arrhythmias. * **Renal Dose Myth:** Low-dose dopamine increases urine output but has **not** been proven to improve survival or prevent acute renal failure in clinical trials. * **Receptor Mnemonic:** Remember the order of activation as **D → β → α** as the dose increases.

Question 88: Which of the following systems is most sensitive to atropine?

A. Respiratory mucosa (Correct Answer)
B. Heart
C. Pupil
D. Gastrointestinal motility

Explanation: **Explanation:** The sensitivity of different organs to atropine follows a predictable, dose-dependent hierarchy. This is a classic high-yield concept in pharmacology known as the **"Order of Atropine Sensitivity."** **1. Why Respiratory Mucosa is Correct:** Atropine is highly potent at inhibiting secretions. The **salivary, sweat, and bronchial (respiratory) glands** are the most sensitive to muscarinic blockade. Even at very low doses (0.5 mg), atropine effectively causes dryness of the mouth and suppression of respiratory tract secretions. This is why it is used as a pre-anesthetic medication to prevent laryngospasm and aspiration. **2. Analysis of Incorrect Options:** * **Heart (B):** The heart is moderately sensitive. Low doses may cause paradoxical bradycardia (due to presynaptic M1 blockade), while higher doses are required to produce the characteristic tachycardia (M2 blockade). * **Pupil (C):** The eye (causing mydriasis and cycloplegia) requires higher doses than those needed to suppress secretions. * **Gastrointestinal Motility (D):** The GI tract and urinary bladder are the **least sensitive** to atropine. Significant inhibition of gastric acid secretion and intestinal motility requires very high doses, which often lead to intolerable side effects (like severe dry mouth and blurred vision). **3. NEET-PG High-Yield Pearls:** * **Order of Sensitivity (Highest to Lowest):** Salivary/Sweat/Bronchial Glands > Eye/Heart > GI tract/Bladder > Gastric Parietal cells. * **Mnemonic:** "Secretions first, Stomach last." * **Clinical Application:** Atropine is the drug of choice for **Organophosphate poisoning** (to reverse muscarinic effects) and **Early Mushroom poisoning**. * **Contraindication:** Avoid in patients with **Glaucoma** (increases intraocular pressure) and **Prostatic Hyperplasia** (causes urinary retention).

Question 89: Preganglionic parasympathetic fibers are characterized by which neurotransmitter?

A. Somatic
B. Parasympathetic
C. Sympathetic
D. Cholinergic (Correct Answer)

Explanation: **Explanation:** The autonomic nervous system (ANS) and somatic nervous system utilize specific neurotransmitters to relay signals. In the ANS, **Acetylcholine (ACh)** is the universal neurotransmitter for all preganglionic fibers, whether they are sympathetic or parasympathetic. Therefore, any fiber that releases acetylcholine is termed **Cholinergic**. 1. **Why the correct answer is right:** Preganglionic parasympathetic fibers originate in the brainstem or sacral spinal cord and travel to ganglia located near or within the effector organs. These fibers release Acetylcholine to stimulate nicotinic receptors ($N_n$) on the postganglionic neuron. Because they utilize ACh, they are classified as cholinergic. 2. **Why other options are wrong:** * **Somatic:** This refers to the system controlling voluntary skeletal muscles. While somatic motor neurons are also cholinergic, "Somatic" describes a functional division of the nervous system, not a neurotransmitter type. * **Parasympathetic/Sympathetic:** These are divisions of the ANS. The question asks for the *characterization* of the fiber based on its neurotransmitter; "Parasympathetic" is the identity of the fiber itself, not its chemical property. **High-Yield Clinical Pearls for NEET-PG:** * **The "All-Preganglionic" Rule:** All preganglionic neurons (Sympathetic and Parasympathetic) and all Somatic motor neurons are **Cholinergic**. * **The Exception:** Most postganglionic sympathetic fibers are **Adrenergic** (release Norepinephrine), except for those supplying **sweat glands** and certain blood vessels in skeletal muscle, which are cholinergic. * **Adrenal Medulla:** It is considered a modified sympathetic ganglion; its preganglionic fibers are also cholinergic.

Question 90: Cholinesterase inhibitors cause all of the following effects, except:

A. Increased salivation
B. Bronchodilation (Correct Answer)
C. Constricted pupils
D. Increased peristalsis

Explanation: **Explanation:** Cholinesterase inhibitors (e.g., Neostigmine, Physostigmine) work by inhibiting the enzyme acetylcholinesterase, leading to an accumulation of **Acetylcholine (ACh)** at the synaptic cleft. This results in generalized stimulation of the parasympathetic nervous system (muscarinic effects). **Why Bronchodilation is the Correct Answer:** ACh acts on **M3 receptors** located in the bronchial smooth muscle. Stimulation of these receptors causes **bronchoconstriction** and increased tracheobronchial secretions. Therefore, cholinesterase inhibitors cause bronchospasm, not bronchodilation. Bronchodilation is a sympathetic (adrenergic) response or a result of anticholinergic drugs (like Ipratropium). **Analysis of Incorrect Options:** * **A. Increased salivation:** ACh stimulates M3 receptors on salivary glands, leading to profuse watery secretions (Sialorrhea). * **C. Constricted pupils:** ACh acts on the sphincter pupillae muscle of the iris (M3 receptors), causing **miosis** (constriction). * **D. Increased peristalsis:** ACh increases the tone and motility of the GI tract smooth muscles and relaxes sphincters, promoting defecation and peristalsis. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Cholinergic Excess:** **DUMBELS** (Diarrhea, Urination, Miosis, Bronchospasm/Bradycardia, Emesis, Lacrimation, Salivation). * **Clinical Contraindication:** Cholinesterase inhibitors should be avoided in patients with **Bronchial Asthma** or COPD due to the risk of severe bronchoconstriction. * **Drug of Choice:** Atropine (an antimuscarinic) is the physiological antagonist used to reverse these muscarinic effects in organophosphate poisoning.

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free